BACKGROUND & AIMS: The appropriate allocation of grafts from HBcAb positive donors in liver transplantation is crucial, yet a consensus is still lacking. METHODS: We evaluated this issue within Liver Match, a prospective observational Italian study. Data from 1437 consecutive, first transplants performed in 2007-2009 using grafts from deceased heart beating donors were analyzed (median follow-up: 1040 days). Of these, 219 (15.2%) were HBcAb positive. Sixty-six HBcAb positive grafts were allocated to HBsAg positive and 153 to HBsAg negative recipients. RESULTS: 329 graft losses occurred (22.9%): 66 (30.1%) among 219 recipients of HBcAb positive grafts, and 263 (21.6%) among 1218 recipients of HBcAb negative grafts. Graft survival was lower in recipients of HBcAb positive compared to HBcAb negative donors, with unadjusted 3-year graft survival of 0.69 (s.e. 0.032) and 0.77 (0.013), respectively (log-rank, p=0.0047). After stratifying for recipient HBsAg status, this difference was only observed among HBsAg negative recipients (log rank, p=0.0007), 3-year graft survival being excellent (0.88, s.e. 0.020) among HBsAg positive recipients, regardless of the HBcAb donor status (log rank, p=0.4478). Graft loss due to de novo HBV hepatitis occurred only in one patient. At Cox regression, hazard ratios for graft loss were: MELD (1.30 per 10 units, p=0.0002), donor HBcAb positivity (1.56, p=0.0015), recipient HBsAg positivity (0.43, p <0.0001), portal vein thrombosis (1.99, p=0.0156), and DRI (1.41 per unit, p=0.0325). CONCLUSIONS: HBcAb positive donor grafts have better outcomes when transplanted into HBsAg positive than HBsAg negative recipients. These findings suggest that donor HBcAb positivity requires more stringent allocation strategies.
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study / Angelico, M; Nardi, Antonella; Marianelli, T; Caccamo, L; Romagnoli, Renato; Tisone, G; Pinna, Antonio Daniele; Avolio, Aw; Fagiuoli, S; Burra, P; Strazzabosco, M; Costa, An; Gerunda, Giorgio Enrico; Liver, Match Investigators. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - STAMPA. - 58(2013), pp. 715-723.
Data di pubblicazione: | 2013 |
Titolo: | Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study. |
Autore/i: | Angelico, M; Nardi, Antonella; Marianelli, T; Caccamo, L; Romagnoli, Renato; Tisone, G; Pinna, Antonio Daniele; Avolio, Aw; Fagiuoli, S; Burra, P; Strazzabosco, M; Costa, An; Gerunda, Giorgio Enrico; Liver, Match Investigators |
Autore/i UNIMORE: | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.jhep.2012.11.025 |
Rivista: | |
Volume: | 58 |
Pagina iniziale: | 715 |
Pagina finale: | 723 |
Codice identificativo ISI: | WOS:000317375600012 |
Codice identificativo Scopus: | 2-s2.0-84880928400 |
Codice identificativo Pubmed: | 23201239 |
Citazione: | Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study / Angelico, M; Nardi, Antonella; Marianelli, T; Caccamo, L; Romagnoli, Renato; Tisone, G; Pinna, Antonio Daniele; Avolio, Aw; Fagiuoli, S; Burra, P; Strazzabosco, M; Costa, An; Gerunda, Giorgio Enrico; Liver, Match Investigators. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - STAMPA. - 58(2013), pp. 715-723. |
Tipologia | Articolo su rivista |
File in questo prodotto:

I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris